Caption Management’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-200
| Closed | -$234 | – | 943 |
|
|
2024
Q2 | $234 | Sell |
200
-73,908
| -100% | -$86.5K | ﹤0.01% | 391 |
|
|
2024
Q1 | $670K | Buy |
+74,108
| New | +$670K | 0.01% | 186 |
|
|
2023
Q4 | – | Sell |
-16,200
| Closed | -$130K | – | 963 |
|
|
2023
Q3 | $130K | Buy |
+16,200
| New | +$130K | ﹤0.01% | 329 |
|
|
2023
Q2 | – | Sell |
-93,778
| Closed | -$647K | – | 841 |
|
|
2023
Q1 | $647K | Sell |
93,778
-9,244
| -9% | -$63.8K | 0.01% | 154 |
|
|
2022
Q4 | $410K | Buy |
+103,022
| New | +$410K | 0.01% | 238 |
|
|
2022
Q2 | – | Sell |
-15,000
| Closed | -$140K | – | 991 |
|
|
2022
Q1 | $140K | Buy |
+15,000
| New | +$140K | ﹤0.01% | 423 |
|
|
2021
Q1 | – | Sell |
-7,989
| Closed | -$98K | – | 817 |
|
|
2020
Q4 | $98K | Sell |
7,989
-106,936
| -93% | -$1.31M | ﹤0.01% | 271 |
|
|
2020
Q3 | $1.48M | Buy |
114,925
+100,925
| +721% | +$1.3M | 0.03% | 90 |
|
|
2020
Q2 | $142K | Hold |
14,000
| – | – | ﹤0.01% | 239 |
|
|
2020
Q1 | $114K | Hold |
14,000
| – | – | 0.01% | 256 |
|
|
2019
Q4 | $121K | Buy |
14,000
+5,000
| +56% | +$43.2K | ﹤0.01% | 249 |
|
|
2019
Q3 | $56K | Sell |
9,000
-17,250
| -66% | -$107K | ﹤0.01% | 237 |
|
|
2019
Q2 | $436K | Sell |
26,250
-11,250
| -30% | -$187K | 0.02% | 147 |
|
|
2019
Q1 | $628K | Sell |
37,500
-5,000
| -12% | -$83.7K | 0.03% | 114 |
|
|
2018
Q4 | $487K | Sell |
42,500
-4,625
| -10% | -$53K | 0.04% | 117 |
|
|
2018
Q3 | $1.89M | Buy |
+47,125
| New | +$1.89M | 0.1% | 43 |
|